Does PALIVIZUMAB Cause Increased bronchial secretion? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Increased bronchial secretion have been filed in association with PALIVIZUMAB (Synagis). This represents 0.2% of all adverse event reports for PALIVIZUMAB.
17
Reports of Increased bronchial secretion with PALIVIZUMAB
0.2%
of all PALIVIZUMAB reports
1
Deaths
16
Hospitalizations
How Dangerous Is Increased bronchial secretion From PALIVIZUMAB?
Of the 17 reports, 1 (5.9%) resulted in death, 16 (94.1%) required hospitalization, and 1 (5.9%) were considered life-threatening.
Is Increased bronchial secretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALIVIZUMAB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does PALIVIZUMAB Cause?
Respiratory syncytial virus infection (1,692)
Pyrexia (1,055)
Death (856)
Bronchiolitis (724)
Cough (665)
Pneumonia (657)
Dyspnoea (466)
Nasopharyngitis (462)
Vomiting (445)
Influenza (398)
What Other Drugs Cause Increased bronchial secretion?
ALBUTEROL (637)
OMALIZUMAB (144)
MEPOLIZUMAB (119)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (93)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (87)
FLUTICASONE\SALMETEROL (86)
FLUTICASONE (82)
PREDNISONE (74)
TIOTROPIUM (65)
BUDESONIDE\FORMOTEROL (63)
Which PALIVIZUMAB Alternatives Have Lower Increased bronchial secretion Risk?
PALIVIZUMAB vs PALONOSETRON
PALIVIZUMAB vs PAMIDRONATE
PALIVIZUMAB vs PAMIDRONIC ACID
PALIVIZUMAB vs PANCRELIPASE
PALIVIZUMAB vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE